Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | DHFR | P00374 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KATNA1 | O75449 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1911845 | 0.80 | CYP11B1 (0.59) | CYP2C9CYP1A2CYP3A4CYP2C19LMNA | |
| SCHEMBL9042497 | 0.79 | P2RX7 (0.42) | CYP1A2TSHRKMT2AMEN1GAA | |
| SCHEMBL12841361 | 0.78 | CYP1A2 (0.47) | CYP2C9CYP1A2KMT2AMEN1NPC1 | |
| SCHEMBL17725702 | 0.76 | KMT2A (0.55) | PTGS2TSHRKMT2AMEN1LMNA | |
| SCHEMBL3344599 | 0.75 | KMT2A (0.51) | CYP2C9CYP1A2TSHRKMT2AMEN1 | |
| SCHEMBL27899616 | 0.74 | MEN1 (0.39) | CYP2C9PTGS2BRD9KMT2AMEN1 | |
| SCHEMBL4427652 | 0.74 | PDE3B (0.40) | CYP2C9CYP1A2PTGS2CYP3A4CYP2C19 | |
| SCHEMBL940333 | 0.74 | TUBB4A (0.44) | CYP2C9CYP1A2PTGS2BRD9KMT2A | |
| SCHEMBL10053481 | 0.73 | PKM (0.48) | CYP2C9CYP1A2KMT2AMEN1NPC1 | |
| SCHEMBL4425136 | 0.73 | NOTUM (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015403-A1 | PROCESS FOR PREPARING IODINATED AZOLES | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-20 | — | — | US | disclosed |
| EP-1979333-A1 | PROCESS FOR PREPARING IODINATED AZOLES | Lanxess Deutschland GmbH (DE) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007085349-A1 | PROCESS FOR PREPARING IODINATED AZOLES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015403-A1 | PROCESS FOR PREPARING IODINATED AZOLES | AZI2, TPO, INSR | CYP2C9 230/4885CYP1A2 107/4885PTGS2 4550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.